CAPRIE(redirected from Clopidogrel vs. Aspirin in Patients at Risk of Ischemic Events)
Conclusion Long-term clopidogrel is more effective than aspirin in decreasing composite end-points for patients with symptomatic ASHD; clopidogrel’s safety is comparable to medium dose aspirin
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.
CAPRIECardiology A clinical trial–Clopidogrel Versus Aspirin in Patients at Risk of Ischemic Events which compared the efficacy of the antiplatelet agent, clopidogrel, with aspirin therapy as a stroke prophylaxis. See Clopidogrel.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.